SynthesisAdvances in therapy2026

Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons.

Jaffer A Ajani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.